Causes of death after congenital heart surgery.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 17383354)

Published in Ann Thorac Surg on April 01, 2007

Authors

Marsha Ma1, Kimberlee Gauvreau, Catherine K Allan, John E Mayer, Kathy J Jenkins

Author Affiliations

1: Tufts University School of Medicine, Boston, Massachusetts, USA.

Articles citing this

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. Intensive Care Med (2010) 1.69

Mortality in infants with cardiovascular malformations. Eur J Pediatr (2011) 1.48

Collaborative quality improvement in the cardiac intensive care unit: development of the Paediatric Cardiac Critical Care Consortium (PC4). Cardiol Young (2014) 1.05

Preoperative factors as a predictor for early postoperative outcomes after repair of congenital transposition of the great arteries. Pediatr Cardiol (2014) 0.89

Myocardial Oxidative Stress in Infants Undergoing Cardiac Surgery. Pediatr Cardiol (2016) 0.80

Unplanned reinterventions are associated with postoperative mortality in neonates with critical congenital heart disease. J Thorac Cardiovasc Surg (2012) 0.79

Usefulness of the maximum rate of pressure rise in the central and peripheral arteries after weaning from cardiopulmonary bypass in pediatric congenital heart surgery: A retrospective analysis. Medicine (Baltimore) (2016) 0.78

Higher pulmonary dead space may predict prolonged mechanical ventilation after cardiac surgery. Pediatr Pulmonol (2009) 0.77

The correlation of fluid balance changes during cardiopulmonary bypass to mortality in pediatric and congenital heart surgery patients. J Extra Corpor Technol (2011) 0.75

Seminal Postoperative Complications and Mode of Death After Pediatric Cardiac Surgical Procedures. Ann Thorac Surg (2016) 0.75

Procalcitonin as a biomarker of bacterial infection in pediatric patients after congenital heart surgery. Ann Pediatr Cardiol (2016) 0.75

Articles by these authors

Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg (2002) 6.92

Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58

Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2007) 4.36

Improvement in congenital heart surgery in a developing country: the Guatemalan experience. Circulation (2007) 3.83

Center-specific differences in mortality: preliminary analyses using the Risk Adjustment in Congenital Heart Surgery (RACHS-1) method. J Thorac Cardiovasc Surg (2002) 2.83

Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med (2006) 2.77

Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol (2004) 2.57

Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54

Accuracy of guideline recommendations for two-dimensional quantification of the right ventricle by echocardiography. Int J Cardiovasc Imaging (2008) 2.26

Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation (2009) 2.26

Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24

Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations. Ann Thorac Surg (2012) 2.22

Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med (2006) 2.18

Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circ Cardiovasc Qual Outcomes (2008) 2.17

Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg (2009) 2.17

Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv (2010) 2.15

Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04

Sudden unexpected death after balloon valvuloplasty for congenital aortic stenosis. J Am Coll Cardiol (2010) 2.02

Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors? Pediatrics (2007) 2.00

Complications and risk factors for mortality during congenital heart surgery admissions. Ann Thorac Surg (2007) 1.98

Characteristics of children hospitalized with infective endocarditis. Circulation (2009) 1.97

Factors associated with increased resource utilization for congenital heart disease. Pediatrics (2005) 1.96

Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart (2013) 1.95

The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics (2006) 1.95

From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94

Aortico-left ventricular tunnel: 35-year experience. J Am Coll Cardiol (2004) 1.93

Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics (2005) 1.87

Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol (2008) 1.83

Identification of pressure passive cerebral perfusion and its mediators after infant cardiac surgery. Pediatr Res (2004) 1.82

Report of the 2010 society of thoracic surgeons congenital heart surgery practice and manpower survey. Ann Thorac Surg (2011) 1.76

Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76

The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg (2003) 1.69

Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg (2008) 1.69

Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr (2010) 1.62

Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology (2004) 1.61

Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr (2004) 1.60

Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg (2011) 1.60

Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59

Low weight as an independent risk factor for adverse events during cardiac catheterization of infants. Catheter Cardiovasc Interv (2013) 1.59

Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg (2011) 1.58

The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg (2008) 1.56

Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg (2005) 1.55

Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54

Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med (2012) 1.53

Congenital heart surgery databases around the world: do we need a global database? Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.50

Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation (2012) 1.50

Birth before 39 weeks' gestation is associated with worse outcomes in neonates with heart disease. Pediatrics (2010) 1.49

Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A. J Heart Lung Transplant (2013) 1.47

Device closure rates of simple atrial septal defects optimized by the STARFlex device. J Am Coll Cardiol (2006) 1.47

Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv (2011) 1.47

Decreased exercise performance with age in children with hypoplastic left heart syndrome. J Pediatr (2007) 1.46

Stratification of complexity improves the utility and accuracy of outcomes analysis in a Multi-Institutional Congenital Heart Surgery Database: Application of the Risk Adjustment in Congenital Heart Surgery (RACHS-1) and Aristotle Systems in the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database. Pediatr Cardiol (2009) 1.46

Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database. Ann Thorac Surg (2012) 1.46

Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg (2012) 1.45

Public reporting of healthcare data: a new frontier in quality improvement. Bull Am Coll Surg (2012) 1.45

A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg (2005) 1.45

Diagnostic errors in pediatric echocardiography: development of taxonomy and identification of risk factors. Circulation (2008) 1.45

Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg (2004) 1.44

Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation (2010) 1.42

Recent results of pulmonary arterial angioplasty: the differences between proximal and distal lesions. Cardiol Young (2005) 1.40

Pulmonary deadspace and postoperative outcomes in neonates undergoing stage 1 palliation operation for single ventricle heart disease. Pediatr Crit Care Med (2014) 1.39

Surgical management of neonatal atrioventricular septal defect with aortic arch obstruction. Ann Thorac Surg (2013) 1.39

Right ventricle to pulmonary artery conduit augmentation compared with replacement in young children. Ann Thorac Surg (2009) 1.39

Physician payment for 2007: a description of the process by which major changes in valuation of cardiothoracic surgical procedures occurred. Ann Thorac Surg (2007) 1.39

Hemodynamic correlates of serum cortisol in neonates after cardiopulmonary bypass. Pediatr Crit Care Med (2011) 1.39

Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials (2006) 1.38

The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials (2005) 1.36

Regional low-flow perfusion versus circulatory arrest in neonates: one-year neurodevelopmental outcome. Ann Thorac Surg (2006) 1.36

Morphology of bicuspid aortic valve in children and adolescents. J Am Coll Cardiol (2004) 1.35

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr (2010) 1.34

A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials (2003) 1.34

Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr (2009) 1.34

Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem (2006) 1.34

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics (2010) 1.33

Early repair of hemitruncus: excellent early and late outcomes. J Thorac Cardiovasc Surg (2007) 1.33

Development of a pediatric cardiology quality improvement collaborative: from inception to implementation. From the Joint Council on Congenital Heart Disease Quality Improvement Task Force. Congenit Heart Dis (2009) 1.32

Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies. Physiol Genomics (2003) 1.31

Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome. Pediatrics (2005) 1.31

Predictors of long-term adverse outcomes in patients with congenital coronary artery fistulae. Circ Cardiovasc Interv (2010) 1.28

Measurement of technical performance in congenital heart surgery: a pilot study. Ann Thorac Surg (2007) 1.27

Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg (2007) 1.27

Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg (2008) 1.26

Factors associated with prolonged recovery after the fontan operation. Circulation (2008) 1.25

Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine. FASEB J (2009) 1.23